Filing search / Longboard Pharmaceuticals, Inc. / "Strategy" / Page 2

8-K

EX-2.1

fyb3cti np3i77xvfaj7

15 Oct 24

Lundbeck to acquire Longboard Pharmaceuticals in a strategic deal, significantly enhancing its neuroscience pipeline

6:14am

PRE 14A

c30tps3qo8yy brs5

28 Mar 24

Preliminary proxy

4:36pm

S-3ASR

b7d7 x51ha6

12 Mar 24

Automatic shelf registration

4:45pm

8-K

EX-99.2

dqm q08oyx

12 Mar 24

Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates

4:10pm

424B5

9d15ie 2k

4 Jan 24

Prospectus supplement for primary offering

4:48pm

424B5

6ryhrwt

2 Jan 24

Prospectus supplement for primary offering

4:54pm

424B5

be8qt2trbkz2

4 Aug 23

Prospectus supplement for primary offering

4:20pm

8-K

EX-99.1

44epuxit1c

5 Dec 22

Regulation FD Disclosure

8:45am

S-3

vjyhc86 wk7e

30 Sep 22

Shelf registration

4:11pm